New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma.
暂无分享，去创建一个
A. Biankin | S. Grimmond | R. Scolyer | A. Nagrial | R. Kefford | G. Long | M. Carlino | D. Yip | C. Saunders | David K. Miller | V. Kwan | J. Tomlinson